Bristol-Myers Squibb Company
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Abstract:

The present invention provides compounds of formula (I): wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases. ##STR00001##